Literature DB >> 31081538

Do T90 and SaO2 nadir identify a different phenotype in obstructive sleep apnea?

Gonzalo Labarca1, Josue Campos2, Katherina Thibaut3, Jorge Dreyse4, Jorge Jorquera4.   

Abstract

INTRODUCTION: Severity of obstructive sleep apnea (OSA) is commonly based upon the apnea-hypopnea index (AHI). However, patients with similar AHIs may demonstrate widely varying comorbidities and risk for cardiovascular disease. These varying manifestations of disease may be related to nocturnal hypoxia and not AHI. We hypothesize that parameters of oxygenation may identify a different phenotype in OSA.
PURPOSE: To explore potential associations between lowest SaO2 (SaO2 nadir) and total sleep time spent with arterial oxygen saturation (SaO2) < 90% (T90) with comorbidities and mortality in patients with moderate and severe OSA.
METHOD: This was a retrospective study of patients between 2009 and 2014, with a new diagnosis of moderate-to-severe OSA without a concomitant respiratory disease. Data collection included demography, comorbidities, sleep study parameters, and mortality over a 5-year interval. Patients were categorized into two groups for analysis, group 1: SaO2 nadir < 75%, and group 2: T90 > 20%.
RESULTS: Of the 365 patients, 163 (45%) recorded SaO2 nadir < 75% and 127 (35%) recorded T90 > 20%. These oxygenation parameters were associated with more severe OSA by AHI (p < 0.001). T90 > 20% was associated with an increased risk of hypertension (HT) OR 2.95 (CI 1.87-4.76, p < 0.001) in patients with both moderate and severe OSA. T90 > 20% was also associated with an increased risk of type 2 diabetes mellitus (T2DM) OR 2.14 (CI 1.35-3.38, p = 0.001) and mortality 2.70 (CI 1.37-5.22, p = 0.0048).
CONCLUSION: The findings demonstrate a correlation between SaO2 nadir < 75% and T90 > 20% and increased severity of OSA. The findings also show a strong association between SaO2 nadir < 75% and T90 > 20% and increased risk for comorbidities of HT and T2DM as well as mortality at 5 years. This analysis suggests that parameters of oxygenation should be used to describe a high-risk phenotype of OSA.

Entities:  

Keywords:  Cardiovascular; Comorbidities; Hypertension; Obstructive; Sleep apnea

Mesh:

Substances:

Year:  2019        PMID: 31081538     DOI: 10.1007/s11325-019-01860-0

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.655


  7 in total

1.  Hypoxia and inflammation indicate significant differences in the severity of obstructive sleep apnea within similar apnea-hypopnea index groups.

Authors:  Aynur Yilmaz Avci; Suat Avci; Huseyin Lakadamyali; Ufuk Can
Journal:  Sleep Breath       Date:  2017-03-07       Impact factor: 2.816

2.  Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from theAmerican College of Physicians.

Authors:  Amir Qaseem; Paul Dallas; Douglas K Owens; Melissa Starkey; Jon-Erik C Holty; Paul Shekelle
Journal:  Ann Intern Med       Date:  2014-08-05       Impact factor: 25.391

3.  Clinical Use of a Home Sleep Apnea Test: An American Academy of Sleep Medicine Position Statement.

Authors:  Ilene M Rosen; Douglas B Kirsch; Ronald D Chervin; Kelly A Carden; Kannan Ramar; R Nisha Aurora; David A Kristo; Raman K Malhotra; Jennifer L Martin; Eric J Olson; Carol L Rosen; James A Rowley
Journal:  J Clin Sleep Med       Date:  2017-10-15       Impact factor: 4.062

4.  Novel parameters indicate significant differences in severity of obstructive sleep apnea with patients having similar apnea-hypopnea index.

Authors:  Antti Kulkas; Pekka Tiihonen; Petro Julkunen; Esa Mervaala; Juha Töyräs
Journal:  Med Biol Eng Comput       Date:  2013-02-16       Impact factor: 2.602

Review 5.  Obstructive sleep apnoea and cardiovascular disease.

Authors:  Manuel Sánchez-de-la-Torre; Francisco Campos-Rodriguez; Ferran Barbé
Journal:  Lancet Respir Med       Date:  2012-11-06       Impact factor: 30.700

6.  TST, as a polysomnographic variable, is superior to the apnea hypopnea index for evaluating intermittent hypoxia in severe obstructive sleep apnea.

Authors:  Xiao-Bin Zhang; Hui-Qing Zen; Qi-Chang Lin; Gong-Ping Chen; Li-Da Chen; Hua Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-16       Impact factor: 2.503

7.  The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea.

Authors:  Haibo Ding; Jie-Feng Huang; Han-Sheng Xie; Bi-Ying Wang; Ting Lin; Jian-Ming Zhao; Qi-Chang Lin
Journal:  Sleep Breath       Date:  2018-10-22       Impact factor: 2.816

  7 in total
  4 in total

1.  Is Vimentin the Cause or Effect of Obstructive Sleep Apnea Development?

Authors:  Buğra Kerget; Dursun Erol Afşin; Ferhan Kerget; Seda Aşkın; Ömer Araz; Metin Akgün
Journal:  Lung       Date:  2020-02-22       Impact factor: 2.584

2.  Impact of mandibular advancement device therapy on cerebrovascular reactivity in patients with carotid atherosclerosis combined with OSAHS.

Authors:  Lu Qin; Na Li; Junyao Tong; Zeliang Hao; Lili Wang; Ying Zhao
Journal:  Sleep Breath       Date:  2021-01-07       Impact factor: 2.816

3.  Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities.

Authors:  John Papanikolaou; Melpomeni Ntalapascha; Demosthenes Makris; Triantafyllia Koukoubani; Vasiliki Tsolaki; George Zakynthinos; Konstantinos Gourgoulianis; Epaminondas Zakynthinos
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

4.  Association of lower nighttime diastolic blood pressure and hypoxia with silent myocardial injury: The Japan Morning Surge-Home Blood Pressure study.

Authors:  Kana Kubota; Satoshi Hoshide; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-13       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.